×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IBRX – immunitybio, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IBRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/29
10:00 am
ibrx
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX
1/27
12:40 pm
ibrx
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX
1/26
08:04 am
ibrx
ImmunityBio (NASDAQ:IBRX) had its price target raised by analysts at HC Wainwright from $8.00 to $10.00. They now have a "buy" rating on the stock.
Medium
Report
ImmunityBio (NASDAQ:IBRX) had its price target raised by analysts at HC Wainwright from $8.00 to $10.00. They now have a "buy" rating on the stock.
1/25
02:02 am
ibrx
Stock Market Today, Jan. 23: ImmunityBio Falls After Gaining Over 200% in a Month [Yahoo! Finance]
Medium
Report
Stock Market Today, Jan. 23: ImmunityBio Falls After Gaining Over 200% in a Month [Yahoo! Finance]
1/23
07:00 am
ibrx
ImmunityBio Reports Median Overall Survival Not Yet Reached and Lymphopenia Reversed in Recurrent Glioblastoma Patients Receiving ANKTIVA® Plus CAR-NK, Chemo-Free Therapy
High
Report
ImmunityBio Reports Median Overall Survival Not Yet Reached and Lymphopenia Reversed in Recurrent Glioblastoma Patients Receiving ANKTIVA® Plus CAR-NK, Chemo-Free Therapy
1/22
07:02 pm
ibrx
ImmunityBio (NASDAQ:IBRX) had its "buy" rating reaffirmed by analysts at BTIG Research.
High
Report
ImmunityBio (NASDAQ:IBRX) had its "buy" rating reaffirmed by analysts at BTIG Research.
1/22
09:41 am
ibrx
Jim Cramer on ImmunityBio: “I Really Think That You Have to Take Profits in Some of That” [Yahoo! Finance]
Medium
Report
Jim Cramer on ImmunityBio: “I Really Think That You Have to Take Profits in Some of That” [Yahoo! Finance]
1/21
06:23 pm
ibrx
Stock Market Today, Jan. 21: ImmunityBio Rises Again As Short-Sellers Face Losses [Yahoo! Finance]
Medium
Report
Stock Market Today, Jan. 21: ImmunityBio Rises Again As Short-Sellers Face Losses [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/26
07:01 am
ibrx
Form 8-K ImmunityBio, Inc. For: Jan 23
Medium
Report
Form 8-K ImmunityBio, Inc. For: Jan 23
1/21
08:35 pm
ibrx
Form 4 ImmunityBio, Inc. For: Jan 20 Filed by: Simon Barry J.
Medium
Report
Form 4 ImmunityBio, Inc. For: Jan 20 Filed by: Simon Barry J.
1/21
08:34 pm
ibrx
Form 4 ImmunityBio, Inc. For: Jan 16 Filed by: Selecky Christobel
Medium
Report
Form 4 ImmunityBio, Inc. For: Jan 16 Filed by: Selecky Christobel
1/20
04:30 pm
ibrx
Form 144 ImmunityBio, Inc. Filed by: Selecky Christobel
Medium
Report
Form 144 ImmunityBio, Inc. Filed by: Selecky Christobel
1/20
11:05 am
ibrx
Form 144 ImmunityBio, Inc. Filed by: Simon Barry J.
High
Report
Form 144 ImmunityBio, Inc. Filed by: Simon Barry J.
1/16
04:22 pm
ibrx
Form 144 ImmunityBio, Inc. Filed by: Selecky Christobel
High
Report
Form 144 ImmunityBio, Inc. Filed by: Selecky Christobel
1/15
08:36 am
ibrx
Form 8-K ImmunityBio, Inc. For: Jan 15
High
Report
Form 8-K ImmunityBio, Inc. For: Jan 15
1/14
08:42 am
ibrx
Form 8-K ImmunityBio, Inc. For: Jan 14
Low
Report
Form 8-K ImmunityBio, Inc. For: Jan 14
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: